3.21.247.95
dgid:
enl:
npi:0
Efgartigimod Safe, Effective in Primary Immune Thrombocytopenia
Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evidence and Advance Personalized Treatment
Jun 01, 2021
ASH: Novel Fetal Hemoglobin Repressor for Sickle Cell Disease Identified
May 31, 2020
Education and Support Enhance Care for Rare-Disease Patients
Mar 27, 2020
/nas/content/live/medjournal3601/wp-content/themes/rd360/single.php
